Crossmark

The benefits of adjuvant chemotherapy are associated with the kind of neoadjuvant therapy in stage ypI rectal cancer: evidence based on population analysis

Crossref DOI link: https://doi.org/10.1007/s00384-023-04530-6

Published Online: 2023-09-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liao, Hualin

Li, Tao

Liang, Yahang

Liu, Yaxiong

Yuan, Yuli

Li, Mingming

Li, Aidi

Liu, Yang

Yao, Yao

Li, Taiyuan
License Information

Text and Data Mining valid from 2023-09-19

Version of Record valid from 2023-09-19
More Information

Article History

Accepted: 10 September 2023

First Online: 19 September 2023

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below